Witryna2 sie 2024 · Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial. - Abstract - Europe PMC Europe PMC is an archive of life sciences journal literature. Europe PMC Witryna1 lut 2024 · Purpose: IMPORT LOW demonstrated noninferiority of partial-breast and reduced-dose radiotherapy versus whole-breast radiotherapy for local relapse and similar or reduced toxicity at 5 years. Comprehensive patient-reported outcome measures collected at serial time points are now reported. Patients and methods: IMPORT LOW …
Patient-Reported Outcomes Over 5 Years After Whole- or Partial …
Witryna30 mar 2024 · Radiation therapy is an integral part of the multidisciplinary management of breast cancer. Regional lymph node irradiation in younger trials seems to provide superior target coverage as well as a reduction in long-term toxicity resulting in a small benefit in the overall survival rate. Witryna25 sty 2016 · Current Trials • IMPORT low • IMPORT high • SUPREMO • FAST • TARGIT 30. ... • Kurtz JM. Radiotherapy for early breast cancer: was a comprehensive overview of trials needed? Lancet. Vol 355: No 9217, 2000; 1739-1740. • Fisher B. Bauer M. Margolese R. et al. Five year results of a randomised clinical trial comparing total … photodirector for acer卸载
Targeted radiotherapy for early breast cancer - The Lancet
Witryna9 wrz 2024 · IMPORT LOW is the first phase 3 trial reporting 5-year outcome data for local relapses and adverse effects after partial-breast radiotherapy delivered using … WitrynaIMPORT LOW Randomised trial testing intensity modulated and partial organ radiotherapy following breast conservation surgery for early breast cancer. Disease site: Breast cancer Treatment modality: Radiotherapy Status: In active follow-up Trial details Witryna29 sie 2024 · Background: IMPORT LOW demonstrated non-inferiority of partial-breast and reduced-dose radiotherapy compared with whole-breast for local relapse, and similar or reduced toxicity at 5 years following radiotherapy. Comprehensive patient reported outcome measures (PROMs) collected at serial time-points are now reported. photodirector for acer bloatware